Ultra Small Batch Manufacture & R&D from Hosokawa Micron
Hosokawa Micron's new series of Picoline machines, developed for ultra small batch production of one to hundreds of grams of material, offers the widest wet and dry processing options for clinical trials or ultra small scale production available on the market. Meeting the demands of R&D departments, research institutes and those processing expensive materials and active pharmaceutical ingredients this unique equipment for size reduction, mixing, classifying and particle design is developed in miniature from existing and proven Hosokawa Micron technology.
The Picoline range comprises nine individual machines, which can all be fitted into the same compact operating housing. The range includes Picoplex based on the UPZ impact mill, Picozirk an impact classifier mill, Picosplit which is an ultrafine air classifier, Picojet based upon the well know AFG opposed jet mill with integral classifier for ultrafine grinding, Piconizer a spiral jet mill, based on the Alpine AS mill, Picocross a pin mill, Picoliq a wet agitated media mill , largely identical to the AHM mill, Picobond a high energy mixer largely identical to the Nobilta product line and Picomix a high performance batch mixer for dry powders. The flexibility of single housing and easily transposable machines is a major plus point.
Developed from established Hosokawa machines, transfer to volume production is straight forward, reliable and problem free enabling a swift route to market for new products under development. Suitable for bench top or housing in a fume cupboard or compact isolator the units are easy to clean and user friendly. Controlled by means of a touch panel with a microprocessor housed within the platform operating data, settings and system flowcharts etc can be displayed and transmitted to external printers, USB sticks or LMS systems.
A range of accessories for feeding, metering, for example, is also available.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance